Ambulatory Blood Pressure for Cardiovascular Risk Stratification
2007; Lippincott Williams & Wilkins; Volume: 115; Issue: 16 Linguagem: Inglês
10.1161/circulationaha.107.697086
ISSN1524-4539
AutoresPaolo Verdecchia, Fabio Angeli, Claudio Cavallini,
Tópico(s)Cardiovascular Health and Disease Prevention
ResumoHomeCirculationVol. 115, No. 16Ambulatory Blood Pressure for Cardiovascular Risk Stratification Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBAmbulatory Blood Pressure for Cardiovascular Risk Stratification Paolo Verdecchia, MD, Fabio Angeli, MD and Claudio Cavallini, MD Paolo VerdecchiaPaolo Verdecchia From Struttura Complessa di Cardiologia, Unità di Ricerca Clinica–Cardiologia Preventiva, Ospedale S. Maria della Misericordia, Perugia, Italy. , Fabio AngeliFabio Angeli From Struttura Complessa di Cardiologia, Unità di Ricerca Clinica–Cardiologia Preventiva, Ospedale S. Maria della Misericordia, Perugia, Italy. and Claudio CavalliniClaudio Cavallini From Struttura Complessa di Cardiologia, Unità di Ricerca Clinica–Cardiologia Preventiva, Ospedale S. Maria della Misericordia, Perugia, Italy. Originally published24 Apr 2007https://doi.org/10.1161/CIRCULATIONAHA.107.697086Circulation. 2007;115:2091–2093Ambulatory blood pressure (ABP) monitoring is increasingly recognized as a valuable tool to refine prediction of cardiovascular risk related to blood pressure (BP).1 After the first landmark study published by Perloff and colleagues 24 years ago,2 several longitudinal event-based studies provided unequivocal evidence of an independent association between ABP and risk of cardiovascular disease. Although experimental procedures and statistical analyses varied from study to study, ABP generally improved cardiovascular risk stratification over and beyond traditional risk factors, including clinic BP.3 The Table, obtained through an electronic search of literature using the terms "ambulatory blood pressure" and "prognosis," shows a list of longitudinal event-based studies performed by independent groups. It is worth noting that the list of available studies is longer because each group generally published other analyses of their database. Only the first-appearing or main contribution from each group has been included in the Table. Longitudinal Event-Based Studies From Independent Groups That Addressed the Prognostic Value of ABPFirst AuthorJournalYear of PublicationSubjects, nFollow-Up, yTotal Events, nFatal Events, nClinical SettingU indicates untreated; T, treated; B, both treated and untreated; and NR, not reported.PerloffJournal of the American Medical Association19831076515375Hypertension (U)VerdecchiaHypertension199411873.28921Hypertension (U)ZweikerActa Medica Austriaca1994116353Hypertension (T)OhkuboJournal of Hypertension199715425.19393Population (B)NakanoDiabetes199832547631Type 2 diabetes (B)RedonHypertension199886421NRHypertension (T)YamamotoStroke19981053.215NRPrevious stroke (T)KhattarCirculation19984799.19838Hypertension (U)StaessenJournal of the American Medical Association19998084.49868Hypertension (U)SuzukiHypertension Research20003104,35712Population (B)SanderCirculation20002863.33614Suspected cerebral ischemia (B)SturrockDiabetic Medicine20007542513Type 1 and 2 diabetes (B)KarioJournal of the American College of Cardiology20019583.56214Hypertension (U)GustavsenJournal of Human Hypertension2003566108016Hypertension (U)ClementNew England Journal of Medicine20031963515778Hypertension (T)BjorklundCirculation20035788.47214Elderly men (U)PierdomenicoAmerican Journal of Hypertension200412794.554NRHypertension (U)FagardJournal of Human Hypertension200539110.98655Population (B)SegaCirculation2005205112NR186Population (B)HansenHypertension200517009.517463Population (B)DolanHypertension200552927.9NR646Hypertension (U)IngelssonJournal of the American Medical Association20069519.170NRAdult men cohort (B)AgarwalKidney International20062573.57552Chronic kidney disease (B)Article p 2145Three aspects of available investigations deserve special mention. First, the prognostic value of ABP has been examined not only in subjects with clinical diagnosis of hypertension but also in the general population and in a variety of settings, including diabetes mellitus, renal failure, and cerebrovascular disease. Second, subjects could be untreated or treated at the time of ABP monitoring. This point may raise concerns, because drug treatment could exert unpredictable effects on 24-hour ABP profile and, consequently, interpretation and applicability of results. Third, although a continuous relation emerged in most studies between ABP and cardiovascular risk, several investigators tried to define clinical categories based on arbitrary thresholds of ABP. Although such categories are potentially useful to make diagnostic and therapeutic decisions in clinical practice, their prognostic role requires confirmation from large and independent cohort studies. Unfortunately, most of the above studies were quite limited in size and hence inadequate to provide universally acceptable clinical implications.The Role of International DatabasesTo overcome the limitations related to relatively small single-center studies, a valuable attempt is being made to join individual data from longitudinal studies that used comparable experimental procedures. For example, one of these databases merged individual data from 4 prospective cohort studies that used similar methodology for recruiting patients and performing 24-hour ABP monitoring.4 In the specific context, the analysis of the database failed to detect differences in the risk of stroke between subjects with white coat hypertension and clinically normotensive control subjects, although the incidence of stroke showed a trend to increase in the long run in the group with white coat hypertension.4 The conclusions of such analysis may be applied to initially untreated subjects with clinical diagnosis of hypertension because of the features of subjects in the database.This issue of Circulation reports the results of the International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) study, a large international database currently composed of 5682 subjects included in prospective population studies from Denmark, Belgium, Japan, and Sweden.5 Of note, all of these studies comprised a random sample of the general population, and all included a longitudinal follow-up with ascertainment of fatal and nonfatal cardiovascular outcome events. The authors ran complex multivariate analyses to determine the ABP thresholds, which resulted in 10-year cardiovascular risks similar to those associated with an optimal (120/80 mm Hg), normal (130/85 mm Hg), and high (140/90 mm Hg) clinic BP. To establish easily recallable thresholds, estimates for cardiovascular events were also reported as rounded to an integer value ending in 0 or 5. In summary, average daytime ABP levels below 120/80 mm Hg were suggested as "optimal," levels <130/85 mm Hg as "normal" and levels ≥140/85 as denoting "ambulatory hypertension." Corresponding thresholds for nighttime ABP were 105/65, 110/70, and 120/70 mm Hg.5 The authors also calculated separate thresholds in the subjects who were untreated at the time of ABP monitoring. As expected, values were slightly higher, particularly for systolic BP, than those obtained in the total sample. Unfortunately, a separate analysis in subjects who were undergoing drug treatment at the time of ABP monitoring is not available.As recognized by the authors, the calculated thresholds were generally lower than those suggested by a working group of the European Society of Hypertension on BP monitoring,6 which, for example, set the daytime ABP normalcy to <135/85 mm Hg, with optimal levels to <130/80 mm Hg. Similar threshold values for daytime ABP normalcy have been suggested by a working group of the American Society of Hypertension.7The findings of IDACO confirm the conclusions of a previous study from our group8 in which the incidence of cardiovascular events did not differ between a normotensive control group and a clinically hypertensive group with white coat hypertension (defined by an average daytime ABP 130 mm Hg for systolic BP and 80 (or perhaps 85) mm Hg for diastolic BP.However, the real challenge with ABP monitoring in the year 2007 would be the implementation of a randomized intervention trial to test the hypothesis that a diagnostic and therapeutic strategy based on ABP and home BP is superior to one based solely on traditional BP measurements in the clinical setting. Progression of target-organ damage and, hopefully, the incidence of cardiovascular events should be the primary end points of such a study. Unfortunately, such a project is something like a "mission impossible," because costs would be very high, and industry may not be interested in supporting such a study in the absence of a potentially adequate return on investment. For example, the hypothesis of a 4-year outcome trial with an anticipated event rate of 2.40 per 100 patient-years in the group guided by clinic BP alone and 2.10 per 100 patient-years in the group guided by ABP and home BP monitoring (ie, a 13% reduction) would require a type I error set to 5% and a power of 90%, which would require 11949 subjects in each group to complete the study and 2144 total events. The number of subjects to randomize would be even higher in relation to the anticipated dropout rate.It is therefore up to scientific societies, working groups and public health authorities to make such a study possible. Given the high prevalence of hypertension and the growing diffusion of ABP monitoring and self-measured BP, such a study would provide invaluable clinical information in the field of preventive cardiology.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.We thank the Associazione Umbria Cuore e Ipertensione for financial support, Carla Jaspers and Francesca Saveri for secretarial help, and Marie Quinn for nursing support.DisclosuresNone.FootnotesCorrespondence to Paolo Verdecchia, MD, FAHA, FACC, Struttura Complessa di Cardiologia, Unità di Ricerca Clinica–Cardiologia Preventiva, Ospedale S. Maria della Misericordia, Piazzale G. Menghini, 06132 Perugia, Italy. E-mail [email protected] References 1 Pickering TG, Shimbo D, Haas D. Ambulatory blood pressure monitoring. N Engl J Med. 2006; 354: 2368–2374.CrossrefMedlineGoogle Scholar2 Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. JAMA. 1983; 249: 2792–2798.CrossrefMedlineGoogle Scholar3 Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000; 35: 844–851.CrossrefMedlineGoogle Scholar4 Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, Imai Y, Ohkubo T, Kario K. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005; 45: 203–208.LinkGoogle Scholar5 Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA; on behalf of the International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007; 115: 2145–2152.LinkGoogle Scholar6 O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P; on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005; 23: 697–701.CrossrefMedlineGoogle Scholar7 Pickering T; for an American Society of Hypertension Ad Hoc Panel. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens. 1996; 9: 1–11.CrossrefMedlineGoogle Scholar8 Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White-coat hypertension. Lancet. 1996; 348: 1444–1445.CrossrefMedlineGoogle Scholar9 Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006; 47: 846–853.LinkGoogle Scholar10 Verdecchia P, Angeli F. How can we use the results of ambulatory blood pressure monitoring in clinical practice? Hypertension. 2005; 46: 25–26.LinkGoogle Scholar11 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206–1252.LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Bursali Ö, Altintaş Ö, Ağir A, Yüksel N and Özkan B (2021) Optical coherence tomography measurements in patients with systemic hypertension, Scottish Medical Journal, 10.1177/00369330211011175, 66:3, (115-121), Online publication date: 1-Aug-2021. Remie C, Roumans K, Moonen M, Connell N, Havekes B, Mevenkamp J, Lindeboom L, de Wit V, van de Weijer T, Aarts S, Lutgens E, Schomakers B, Elfrink H, Zapata-Pérez R, Houtkooper R, Auwerx J, Hoeks J, Schrauwen-Hinderling V, Phielix E and Schrauwen P (2020) Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans, The American Journal of Clinical Nutrition, 10.1093/ajcn/nqaa072, 112:2, (413-426), Online publication date: 1-Aug-2020. Kario K, Thijs L and Staessen J (2019) Blood Pressure Measurement and Treatment Decisions, Circulation Research, 124:7, (990-1008), Online publication date: 29-Mar-2019. Lopez-Sublet M, Girerd N, Bozec E, Machu J, Ferreira J, Zannad F, Mourad J and Rossignol P (2019) Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study), American Journal of Hypertension, 10.1093/ajh/hpz020, 32:7, (620-628), Online publication date: 11-Jun-2019. Carey R, Calhoun D, Bakris G, Brook R, Daugherty S, Dennison-Himmelfarb C, Egan B, Flack J, Gidding S, Judd E, Lackland D, Laffer C, Newton-Cheh C, Smith S, Taler S, Textor S, Turan T and White W (2018) Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association, Hypertension, 72:5, (e53-e90), Online publication date: 1-Nov-2018. White W and Malha L (2018) Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management Hypertension: A Companion to Braunwald's Heart Disease, 10.1016/B978-0-323-42973-3.00011-1, (96-103), . Krmar R and Ferraris J (2017) Clinical value of ambulatory blood pressure in pediatric patients after renal transplantation, Pediatric Nephrology, 10.1007/s00467-017-3781-6, 33:8, (1327-1336), Online publication date: 1-Aug-2018. Campbell P and White W (2017) Utility of ambulatory blood pressure monitoring for the management of hypertension, Current Opinion in Cardiology, 10.1097/HCO.0000000000000399, 32:4, (365-372), Online publication date: 1-Jul-2017. White W, Myers M, Jordan R and Lucas J (2017) Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide, Journal of Hypertension, 10.1097/HJH.0000000000001221, 35:4, (761-768), Online publication date: 1-Apr-2017. Angeli F, Reboldi G and Verdecchia P (2016) Home blood pressure and treatment decisions, Journal of Hypertension, 10.1097/HJH.0000000000000999, 34:8, (1494-1496), Online publication date: 1-Aug-2016. Choi S, Kim S, Park S, Kim J, Ihm S, Kim G, Kim W, Pyun W, Kim Y and Shin J (2016) Prevalence of resistant hypertension and associated factors for blood pressure control status using Korean ambulatory blood pressure monitoring registry data, Clinical Hypertension, 10.1186/s40885-016-0045-x, 22:1, Online publication date: 1-Dec-2016. Angeli F and Verdecchia P (2016) Prognostic Value of Ambulatory Blood Pressure Monitoring Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, 10.1007/978-3-319-22771-9_9, (165-191), . White W and Malha L (2016) Ambulatory Blood Pressure Monitoring in Clinical Trials of Drugs and Devices Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, 10.1007/978-3-319-22771-9_20, (371-393), . Townsend R and Taler S (2015) Management of hypertension in chronic kidney disease, Nature Reviews Nephrology, 10.1038/nrneph.2015.114, 11:9, (555-563), Online publication date: 1-Sep-2015. Angeli F, Reboldi G and Verdecchia P (2015) Interpretation of ambulatory blood pressure profile, Journal of Hypertension, 10.1097/HJH.0000000000000497, 33:3, (454-457), Online publication date: 1-Mar-2015. Shin J, Park S, Kim J, Ihm S, Kim K, Kim W, Pyun W, Kim Y, Choi S and Kim S (2015) Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group, The Korean Journal of Internal Medicine, 10.3904/kjim.2015.30.5.610, 30:5, (610-619) Turner J, Viera A and Shimbo D (2015) Ambulatory Blood Pressure Monitoring in Clinical Practice: A Review, The American Journal of Medicine, 10.1016/j.amjmed.2014.07.021, 128:1, (14-20), Online publication date: 1-Jan-2015. Gök M, Karabas V, Emre E, Aksar A, Aslan M and Ural D (2015) Evaluation of choroidal thickness via enhanced depth-imaging optical coherence tomography in patients with systemic hypertension, Indian Journal of Ophthalmology, 10.4103/0301-4738.156928, 63:3, (239), . White W, Turner J, Sica D, Bisognano J, Calhoun D, Townsend R, Aronow H, Bhatt D and Bakris G (2014) Detection, evaluation, and treatment of severe and resistant hypertension, Journal of the American Society of Hypertension, 10.1016/j.jash.2014.06.005, 8:10, (743-757), Online publication date: 1-Oct-2014. Angeli F, Reboldi G, Poltronieri C, Bartolini C, D'Ambrosio C, de Filippo V and Verdecchia P (2014) Clinical utility of ambulatory blood pressure monitoring in the management of hypertension, Expert Review of Cardiovascular Therapy, 10.1586/14779072.2014.903155, 12:5, (623-634), Online publication date: 1-May-2014. Angeli F, Verdecchia P, Poltronieri C, Bartolini C, de Filippo V, D'Ambrosio C and Reboldi G (2014) Ambulatory blood pressure monitoring in the elderly: Features and perspectives, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2014.04.004, 24:10, (1052-1056), Online publication date: 1-Oct-2014. Seif F, Patel S, Walia H, Rueschman M, Bhatt D, Blumenthal R, Quan S, Gottlieb D, Lewis E, Patil S, Punjabi N, Babineau D, Redline S and Mehra R (2014) Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk, Journal of Hypertension, 10.1097/HJH.0000000000000011, 32:2, (267-275), Online publication date: 1-Feb-2014. Ozdemir E, Yildirimturk O, Cengiz B, Yurdakul S and Aytekin S (2013) Evaluation of Carotid Intima-Media Thickness and Aortic Elasticity in Patients with Nondipper Hypertension, Echocardiography, 10.1111/echo.12444, 31:5, (663-668), Online publication date: 1-May-2014. Angeli F, Verdecchia P, Pascucci C, Poltronieri C and Reboldi G (2013) Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension, Expert Opinion on Drug Metabolism & Toxicology, 10.1517/17425255.2013.769521, 9:3, (379-385), Online publication date: 1-Mar-2013. Lin W, Zhang H and Zhang Y (2013) Investigation on Cardiovascular Risk Prediction Using Physiological Parameters, Computational and Mathematical Methods in Medicine, 10.1155/2013/272691, 2013, (1-21), . Sager P, Heilbraun J, Turner J, Gintant G, Geiger M, Kowey P, Mansoor G, Mendzelevski B, Michelson E, Stockbridge N, Weber M and White W (2013) Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium, American Heart Journal, 10.1016/j.ahj.2013.01.002, 165:4, (477-488), Online publication date: 1-Apr-2013. deGoma E, Knowles J, Angeli F, Budoff M and Rader D (2012) The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease, Cardiology in Review, 10.1097/CRD.0b013e318239b924, 20:3, (118-129), Online publication date: 1-May-2012. Vasunta R, Kesäniemi Y, Ylitalo A and Ukkola O (2012) Nondipping Pattern and Carotid Atherosclerosis in a Middle-Aged Population: OPERA Study, American Journal of Hypertension, 10.1038/ajh.2011.159, 25:1, (60-66), Online publication date: 1-Jan-2012., Online publication date: 1-Jan-2012. Koc Y, Unsal A, Kayabasi H, Oztekin E, Sakaci T, Ahbap E, Yilmaz M and Akgun A (2011) Impact of Volume Status on Blood Pressure and Left Ventricle Structure in Patients Undergoing Chronic Hemodialysis, Renal Failure, 10.3109/0886022X.2011.565139, 33:4, (377-381), Online publication date: 1-May-2011. Agarwal R and Light R (2009) The Effect of Measuring Ambulatory Blood Pressure on Nighttime Sleep and Daytime Activity—Implications for Dipping, Clinical Journal of the American Society of Nephrology, 10.2215/CJN.07011009, 5:2, (281-285), Online publication date: 1-Feb-2010. Cohen D and Townsend R (2010) Is Ambulatory Blood Pressure Monitoring Finally Catching On?, The Journal of Clinical Hypertension, 10.1111/j.1751-7176.2009.00243.x, 12:3, (193-194), Online publication date: 1-Mar-2010. Angeli F, Reboldi G and Verdecchia P (2010) Masked Hypertension: Evaluation, Prognosis, and Treatment, American Journal of Hypertension, 10.1038/ajh.2010.112, 23:9, (941-948), Online publication date: 1-Sep-2010. Dolan E, Stanton A, Thom S, Caulfield M, Atkins N, McInnes G, Collier D, Dicker P and O'Brien E (2009) Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients – an Anglo-Scandinavian cardiac outcomes trial substudy, Journal of Hypertension, 10.1097/HJH.0b013e328322cd62, 27:4, (876-885), Online publication date: 1-Apr-2009. Conen D and Bamberg F (2008) Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis, Journal of Hypertension, 10.1097/HJH.0b013e3282f97854, 26:7, (1290-1299), Online publication date: 1-Jul-2008. Verdecchia P, Angeli F and Reboldi G (2008) Optimizing the definition of dippers and nondippers: is a 70–86% full glass empty?, Journal of Hypertension, 10.1097/HJH.0b013e3282f4dbbc, 26:4, (630-632), Online publication date: 1-Apr-2008. Angeli F, Repaci S, Borgioni C, Sardone M, Scotti A and Verdecchia P (2008) Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label noncomparison study, Current Therapeutic Research, 10.1016/j.curtheres.2008.06.003, 69:3, (207-220), Online publication date: 1-Jun-2008. Kanbay M, Turgut F, Erkmen Uyar M, Akcay A and Covic A (2009) Causes and Mechanisms of Nondipping Hypertension, Clinical and Experimental Hypertension, 10.1080/10641960802251974, 30:7, (585-597), Online publication date: 1-Jan-2008. Coll-de-Tuero G, Saez M, Roca-Saumell C, Rodriguez-Poncelas A, Franco P, Dalfó A, Calvó-Perxas L, Pose-Reino A and Bayó-Llibre J (2012) Evolution of Target Organ Damage by Different Values of Self-Blood Pressure Measurement in Untreated Hypertensive Patients, American Journal of Hypertension, 10.1038/ajh.2012.126 Gottfridsson C, Panfilov S, Ebrahimi A, Gigger E, Pollard C, Henderson S, Ambery P and Raichlen J (2016) Drug-induced blood pressure increase – recommendations for assessment in clinical and non-clinical studies, Expert Opinion on Drug Safety, 10.1080/14740338.2017.1259615, (1-11) Richter C, Skulas-Ray A, Gaugler T, Meily S, Petersen K and Kris-Etherton P (2021) Effects of Cranberry Juice Supplementation on Cardiovascular Disease Risk Factors in Adults with Elevated Blood Pressure: A Randomized Controlled Trial, Nutrients, 10.3390/nu13082618, 13:8, (2618) April 24, 2007Vol 115, Issue 16 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.107.697086PMID: 17452617 Originally publishedApril 24, 2007 Keywordshypertensioncircadian rhythmblood pressurediagnosisprognosispreventionEditorialsPDF download Advertisement SubjectsClinical StudiesEpidemiology
Referência(s)